Track Ventyx Biosciences's accounts payable ($990K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest accounts payable for VTYX is $990K as of September 2025. That compares with $2.3M in the prior-year period — down 56.6% year over year. Investors often review this figure alongside Ventyx Biosciences's historical trend and sector peers before judging valuation or financial health.
Over the past year, VTYX's accounts payable moved from $2.3M to $990K — a 56.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ventyx Biosciences's operating scale or balance-sheet position.
A accounts payable figure of $990K for VTYX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting VTYX's accounts payable ($990K), review year-over-year change from $2.3M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.